By Tony Fong

NEW YORK (GenomeWeb News) – Coming off a soft second quarter, Greg Lucier, CEO of Life Technologies said at the UBS Global Life Sciences Conference today that the company is "now repositioning" itself for the challenges it faces ahead and has started the process of righting itself.

He also highlighted the performance of Life Tech's Ion Torrent Personal Genome Machine benchtop sequencer, saying it has seen "incredible uptake."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Sponsored by

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.